Additionally, the ratio of CD8+ to FoxP3+ TILs in the pCR/MPR group is significantly greater than in the pPR/pNR group, suggesting that this ratio could emerge as a novel biomarker after nCIT in ESCC. Here, CD8A is linked to esophageal squamous cell carcinoma.